Jiangsu Nhwa Pharmaceutical Co Ltd Financial Flexibility Index
Jiangsu Nhwa Pharmaceutical Co Ltd financial flexibility index. Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Financial Flexibility Index of 0.50x as of September 2025. Free cash flow of CN¥506.78 Million (operating CF CN¥425.83 Million minus capex CN¥80.95 Million) represents 1% of total liabilities (CN¥1.00 Billion). See Jiangsu Nhwa Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)
Financial flexibility index of Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025. Historical Financial Flexibility Index trend for Jiangsu Nhwa Pharmaceutical Co Ltd across 21 annual periods. Check cash flow quality index of Jiangsu Nhwa Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Jiangsu Nhwa Pharmaceutical Co Ltd Financial Flexibility Index by Year (2005–2025)
Jiangsu Nhwa Pharmaceutical Co Ltd financial flexibility index by year from 2005 to 2025. Year-by-year free cash flow to debt coverage for Jiangsu Nhwa Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Jiangsu Nhwa Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.27x | CN¥1.52 Billion | CN¥1.08 Billion | CN¥1.20 Billion | ▲ +8.3% |
| 2024 | 1.17x | CN¥1.37 Billion | CN¥916.13 Million | CN¥1.17 Billion | ▼ -22.2% |
| 2023 | 1.51x | CN¥1.38 Billion | CN¥1.01 Billion | CN¥918.09 Million | ▲ +13.7% |
| 2022 | 1.32x | CN¥1.19 Billion | CN¥861.02 Million | CN¥897.43 Million | ▲ +15.9% |
| 2021 | 1.14x | CN¥907.22 Million | CN¥701.12 Million | CN¥793.45 Million | ▼ -46.7% |
| 2020 | 2.15x | CN¥1.52 Billion | CN¥1.25 Billion | CN¥706.67 Million | ▲ +174.7% |
| 2019 | 0.78x | CN¥466.27 Million | CN¥305.97 Million | CN¥596.68 Million | ▲ +46.0% |
| 2018 | 0.54x | CN¥575.22 Million | CN¥404.52 Million | CN¥1.07 Billion | ▼ -27.3% |
| 2017 | 0.74x | CN¥618.36 Million | CN¥452.35 Million | CN¥840.24 Million | ▲ +65.1% |
| 2016 | 0.45x | CN¥379.36 Million | CN¥277.14 Million | CN¥850.97 Million | ▼ -23.4% |
| 2015 | 0.58x | CN¥420.87 Million | CN¥204.24 Million | CN¥723.60 Million | ▲ +19.1% |
| 2014 | 0.49x | CN¥421.84 Million | CN¥160.24 Million | CN¥863.61 Million | ▲ +19.7% |
| 2013 | 0.41x | CN¥297.96 Million | CN¥194.33 Million | CN¥730.13 Million | ▲ +16.4% |
| 2012 | 0.35x | CN¥232.17 Million | CN¥154.16 Million | CN¥662.41 Million | ▲ +48.0% |
| 2011 | 0.24x | CN¥127.28 Million | CN¥81.08 Million | CN¥537.59 Million | ▼ -21.0% |
| 2010 | 0.30x | CN¥147.36 Million | CN¥61.79 Million | CN¥491.74 Million | ▲ +11.5% |
| 2009 | 0.27x | CN¥103.42 Million | CN¥61.27 Million | CN¥384.68 Million | ▲ +23.6% |
| 2008 | 0.22x | CN¥83.90 Million | CN¥46.50 Million | CN¥385.66 Million | ▲ +6.8% |
| 2007 | 0.20x | CN¥90.51 Million | CN¥48.55 Million | CN¥444.39 Million | ▲ +15.9% |
| 2006 | 0.18x | CN¥67.08 Million | CN¥30.99 Million | CN¥381.63 Million | ▲ +53.7% |
| 2005 | 0.11x | CN¥40.83 Million | CN¥8.84 Million | CN¥357.12 Million | — |